Skip to main content
SpringerLink
Log in

Influence of Crystal Habit on Trimethoprim Suspension Formulation

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The role of crystal habit in influencing the physical stability and pharmacokinetics of trimethoprim suspensions was examined.

Methods. Different habits of trimethoprim (TMP) were obtained by recrystallizing the commercial sample (PD) utilizing solvent-change precipitation method. Four distinct habits (microscopic observation) belonging to the same polymorphic state (DSC studies) were selected for studies. Preformulation and formulation studies were carried out on suspension dosage forms containing these crystals. The freshly prepared suspensions were also evaluated for their pharmacokinetic behaviour on healthy human volunteers using a cross over study.

Results. Variation of crystallization conditions produces different habits of TMP. Among the different crystal habits exhibiting same polymorphic state, the most anisometric crystal showed best physical stability in terms of sedimentation volume and redispersibility. However, habit did not significantly affect the extent of TMP excreted in urine.

Conclusions. Modification of surface morphology without significantly altering the polymorphic state can be utilized for improving physical stability of TMP suspensions. However, the pharmacokinetic profile remains unaltered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. J. K. Haleblian. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J. Pharm. Sci. 64:1269–1288 (1975).

    Google Scholar 

  2. H. Takubo, S. Kume, and M. Koizumi. Relationships between supersaturation, solution velocity, crystal habit and growth rate in crystallization of ammonium phosphate. J. Cryst. Growth. 67:217–226 (1984).

    Google Scholar 

  3. J. Jaffe and N. E. Foss. Compression of crystalline substances. J. Am. Pharm. Assoc. Sci. ed. XLVIII:26–29 (1959).

    Google Scholar 

  4. J. W. Shell. X-ray and crystallographic applications in pharmaceutical research. III. Crystal habit quantitation. J. Pharm. Sci. 52:100–101 (1963).

    Google Scholar 

  5. O. Alpar, J. A. Hersey, and E. Shotton. Compression properties of lactose. J. Pharm. Pharmacol. 22S:1S–7S (1970).

    Google Scholar 

  6. E. Shotton and B. A. Obiorah. Effect of particle shape and crystal habit on properties of sodium chloride. J. Pharm. Pharmacol. 25S:37p–43 p (1973).

    Google Scholar 

  7. M. P. Summers, R. P. Enever, and J. E. Carless. Influence of crystal form on radial stress transmission characteristics of pharmaceutical materials. J. Pharm. Pharmacol. 28:89–99 (1976).

    Google Scholar 

  8. R. E. Gordon and S. I. Amin. European Patent 0 120 587 BI (1986).

  9. S. Byrn, R. Pfeiffer, M. Ganey, C. Hoiberg, and G. Poochikian. Pharmaceutical solids: A strategic approach to regulatory considerations. Pharm. Res. 12:945–954 (1995).

    Google Scholar 

  10. W. C. Winslow. Pers. Commun. In K. Florey, (ed)., Analytical Profiles of Drug Substances, Vol. 7, Academic Press, New York, 1989, p. 453.

    Google Scholar 

  11. S. A. Kaplan, R. E. Weinfeld, and T. L. Lee. Semiautomated spectrofluorometric determination of trimethoprim in biological fluids. J. Pharm. Sci. 62:1865–1870 (1973).

    Google Scholar 

  12. J. T. Carstensen. Theory of Pharmaceutical Systems: Heterogeneous System, Vol II, Academic Press, New York, 1973, p. 262.

    Google Scholar 

  13. E. G. Shami, J. R. Dudzinski, and R. J. Lantz Jr. The Theory and Practice of Industrial Pharmacy, L. Lachman, H. A. Lieberman, and J. L. Kanig, (eds)., K. M. Varghese Co., Bombay, 1976, p. 18.

    Google Scholar 

  14. P. V. Allen, P. D. Rahn, A. C. Sarapu, and A. J. Vanderwielen. Physical characterization of erythromycin: anhydrate, monohydrate and dihydrate crystalline solids. J. Pharm. Sci. 67:1087–1093 (1978).

    Google Scholar 

  15. V. Gallardo, A. V. Delgado, A. Parera, and J. S. Salcedo. Electrophoretic study of nitrofurantoin in aqueous suspensions. Effect of addition of a polymer thickener. J. Pharm. Pharmacol. 42:225–229 (1990).

    Google Scholar 

  16. D. L. Simmons, R. L. Ranz, and N. D. Gyanchandani. Polymorphism in pharmaceuticals. III. Chlorpropamide. Can. J. Pharm. Sci. 8:125–127 (1973).

    Google Scholar 

  17. A. Dresse, M. A. Gegard, and A. Lays. Human pharmacokinetics of two crystalline and galenic forms of diflunisal, a new analgesic. Pharm. Acta Helv. 53:177–181 (1978).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, 147 002, India

    Ashok K. Tiwary

  2. Department of Pharmaceutical Sciences, B.I.T., Mesra, Ranchi, 835 215, India

    Gopal M. Panpalia

Authors
  1. Ashok K. Tiwary
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gopal M. Panpalia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ashok K. Tiwary.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tiwary, A.K., Panpalia, G.M. Influence of Crystal Habit on Trimethoprim Suspension Formulation. Pharm Res 16, 261–265 (1999). https://doi.org/10.1023/A:1018832526093

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018832526093

Search

Navigation